Company
MindImmune Therapeutics
KingstonBiotechnologyHealthcareHealth CareTherapeuticsDescription
MindImmune Therapeutics announced the appointment of Isaac Stoner as Chief Executive Officer following a $10.2 million Series A extension. This brings total funding to $30 million to advance its Alzheimer’s therapy into clinical development.
Quick answer
MindImmune Appoints Isaac Stoner as Chief Executive Officer (November 24, 2025). MindImmune Therapeutics is based in Kingston, Rhode Island, United States.
- What did MindImmune Therapeutics announce on November 24, 2025?
- MindImmune Therapeutics announced the appointment of Isaac Stoner as Chief Executive Officer following a $10.2 million Series A extension. This brings total funding to $30 million to advance its Alzheimer’s therapy into clinical development.
- What does MindImmune Therapeutics do?
- MindImmune Therapeutics is a venture-backed biotechnology company developing products that target the immunological drivers of neurodegenerative disease.
- Where is MindImmune Therapeutics based?
- MindImmune Therapeutics is based in Kingston, Rhode Island, United States.
- Which similar companies made leadership changes around the same time?
- BioCardia (November 24, 2025), Ovid Therapeutics (December 2, 2025), QurAlis (November 10, 2025) and Enliven Therapeutics (December 11, 2025) also announced leadership changes within 45 days of MindImmune Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BioCardia Appoints New Vice President of Quality (November 24, 2025)
- Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer (December 2, 2025)
- QurAlis Appoints Manoj Malhotra, M.D., as Chief Medical Officer (November 10, 2025)
- Enliven Appoints Rick Fair as Chief Executive Officer (December 11, 2025)
- Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer (January 6, 2026)
- NovaBridge's Visara Appoints Cadmus C. Rich as Chief Medical Officer (November 21, 2025)
Who to call at MindImmune Therapeutics, and when
A new leader at MindImmune Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day MindImmune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MindImmune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MindImmune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MindImmune Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MindImmune Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.